Department of Cardiology, Hebei Province Hospital of Chinese Medicine, No. 389 of Zhongshan East Street, Chang'an District, Shijiazhuang, 050000, Hebei, China.
Department of Internal Medicine, Hebei Province Hospital of Chinese Medicine, Shijiazhuang, 050000, Hebei, China.
Eur J Med Res. 2023 Mar 12;28(1):115. doi: 10.1186/s40001-022-00944-0.
To investigate the prediction of long-term blood pressure control using the intestinal flora of patients with hypertension.
A total of 125 patients with primary grade-2 hypertension who attended the cardiovascular department of Hebei Province Hospital of Chinese Medicine between April 2021 and April 2022 were enrolled; these included 65 patients with substandard long-term blood pressure control (the uncontrolled group) and 60 patients with standard long-term blood pressure control (the controlled group). General clinical data and data on morning stools and diet were recorded for all the enrolled patients. The 16 s rDNA sequencing of faecal intestinal flora was also performed to analyse the differences in intestinal flora between the two groups of patients and to investigate the relationship between blood pressure compliance and the presence of flora.
The intestinal flora of the two groups of patients differed in terms of the Firmicutes-Bacteroidetes ratio (F/B), α-diversity analysis (Chao1, ACE and Shannon) results and β-diversity analysis results. At the genus level, the number of Streptococcus and Paraprevotella in patients in the uncontrolled group was greater than that of the controlled group, and the level of Akkermansia and Bifidobacterium was lower than that in the controlled group. A logistic regression analysis of the difference factors found differences in ACE, F/B, Streptococcus, Paraprevotella and Akkermansia in the two groups; these differences remained after correcting for age, gender and body mass index. The receiver operating characteristic curves revealed the following: ACE (area under the curve [AUC] = 85.282), Streptococcus (AUC = 82.705), Akkermansia (AUC = 77.333), Paraprevotella (AUC = 66.154) and F/B (AUC = 60.436).
There were significant differences in the intestinal flora of the patients in the controlled blood group compared with that of the uncontrolled group. Therefore, the ACE, genus levels of Streptococcus and Akkermansia could provide some prediction of late blood pressure compliance or non-compliance in patients with hypertension.
探讨利用高血压患者肠道菌群预测长期血压控制情况。
选取 2021 年 4 月至 2022 年 4 月河北省中医院心血管科就诊的 125 例原发性 2 级高血压患者,其中 65 例长期血压控制不达标(未控制组),60 例长期血压控制达标(控制组)。记录所有入组患者的一般临床资料、清晨大便及饮食情况,行粪便肠道菌群 16s rDNA 测序,分析两组患者肠道菌群差异,探讨菌群与血压达标情况的关系。
两组患者肠道菌群在厚壁菌门-拟杆菌门比值(F/B)、α多样性分析(Chao1、ACE 和 Shannon)结果和β多样性分析结果方面存在差异。在属水平上,未控制组患者中链球菌和拟普雷沃氏菌数量多于控制组,阿克曼氏菌和双歧杆菌水平低于控制组。对差异因素进行 logistic 回归分析,发现两组 ACE、F/B、链球菌、拟普雷沃氏菌和阿克曼氏菌存在差异,经年龄、性别和体重指数校正后差异仍有统计学意义。受试者工作特征曲线显示:ACE(曲线下面积[AUC]=85.282)、链球菌(AUC=82.705)、阿克曼氏菌(AUC=77.333)、拟普雷沃氏菌(AUC=66.154)和 F/B(AUC=60.436)。
控制血压组患者肠道菌群与未控制血压组患者存在明显差异,因此 ACE、链球菌属和阿克曼氏菌属水平可对高血压患者晚期血压达标或不达标提供一定预测。